Employees Retirement System of Texas’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$226K Hold
44,679
﹤0.01% 355
2025
Q1
$236K Hold
44,679
﹤0.01% 249
2024
Q4
$302K Hold
44,679
﹤0.01% 287
2024
Q3
$294K Sell
44,679
-5,672
-11% -$37.3K ﹤0.01% 311
2024
Q2
$378K Buy
50,351
+5,953
+13% +$44.7K ﹤0.01% 287
2024
Q1
$443K Buy
44,398
+22,000
+98% +$220K ﹤0.01% 296
2023
Q4
$221K Buy
+22,398
New +$221K ﹤0.01% 320